Major medical insurance: What kind of medical device industry will profit?
Recently, the General Office of the State Council issued the "Opinions on the Comprehensive Implementation of Urban and Rural Residents' Disease Insurance" (hereinafter referred to as the opinion). The opinion is that in 2015, the proportion of major illness insurance payment should reach more than 50%; before the end of the year, the major illness insurance covers all urban and rural residents' basic medical insurance. To protect the population, the burden of medical treatment for seriously ill patients is effectively reduced. Formally means that major illness insurance has been fully activated. According to the data of the Ministry of Social Security, the number of people covered by major illness insurance will increase from about 700 million to 1 billion. The fund-raising share is currently about 30 yuan/person/year. The total size of major illness assets is about 30-400 billion yuan. The future funding sources are expected to be diversified. The scale will also increase. So what will the major illness insurance market bring to the entire medical device market as a newly launched market? On the whole, China's medical insurance policy will benefit the following types of medical machinery industry: (1) High-end medical equipment With the full launch of the major illness insurance, the medical insurance system will cover every citizen and start from the ground up to drive the popularity of domestic medical care and the public's emphasis on self-health. At the same time as the increase in the disposable income of the people, the rapid rise of the middle class population has also driven the change of consumption patterns, paying more attention to personal health, and gradually turning to product quality. According to data surveys, 80% of the population said that they are increasingly worried about health issues, and more than 90% tend to buy higher quality products. In other words, under the premise of increasing the proportion of major illness insurance payments, if the product quality and specifications are of the same type, the price is the secondary consideration for the people. In general, the basic cost of medical insurance is considered, and the import substitution of high-quality medical devices is favored, including domestically-made innovative medical devices, high-quality medical devices and medical device products with exact curative effects. For example, Lepu, Yuyue and other domestic high-quality medical equipment products. (2) Dialysis medical equipment The medical insurance for major illnesses has comprehensively promoted and clarified the time node and the proportion of claims. This is a new change in the pattern of medical insurance in China, which has far-reaching impact on the medical and pharmaceutical industry chain. End-stage renal disease is the coverage of major medical insurance, but only 20% of patients in the country are subject to standard treatment of peritoneal or hemodialysis. If the implementation of major medical insurance will increase the penetration rate of kidney disease dialysis. With the increasing proportion of medical insurance reimbursement and the increasing attention paid to dialysis treatment, the market demand for the dialysis industry is constantly being stimulated. From 2011 to 2013, the market growth rate of domestic dialysis machines and dialyzers reached 25% to 30%. It is expected that there will be a tens of billions of demand in the market in the next 5 to 6 years. According to public information, there are currently about 2 million end-stage renal disease patients in the country, and only about 300,000 of them will receive dialysis treatment, accounting for only 15%. According to the "Green Paper on China's Health Development" issued by the Ministry of Health in 2012, the annual direct treatment fee for each hemodialysis patient is 75,100 yuan. According to this calculation, the market demand for dialysis treatment in China is about 20 billion yuan. If the remaining 85% of patients are able to receive regular dialysis treatment, it will further release hundreds of billions of potential market demand. At present, the incidence of end-stage renal disease in China should be at the world average. According to the theoretical incidence rate, the number of patients exceeds 2 million, the treatment cost is about 70,000 yuan/person, and the theoretical market space is over 100 billion yuan. (3) Innovative devices Innovative medical devices may be supported by the major illness insurance policy. Under the background that the current innovative devices are difficult to enter the medical insurance catalogue, the opinions pointed out that it is necessary to promote the innovative development of medical devices and medical technologies, and provide inclined support in the proportion of the cost of commercial health insurance, and accelerate the formation of strategic emerging industries. It is also worth noting that the pace of import substitution of domestic high-quality medical devices is expected to accelerate further. For their own benefit, insurance companies will pay great attention to the efficiency of capital utilization when they operate commercial health insurance. Domestic medical devices will be expected to be favored by commercial health insurance companies by virtue of their high quality and low price. Yancheng Rongtai Labware Co.,Ltd , https://www.shtestlab.com